| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044997 Methods |
| 02/24/2011 | US20110044996 Neutralizing antibodies |
| 02/24/2011 | US20110044988 Methods of treatment using anti-mif antibodies |
| 02/24/2011 | US20110044981 Methods and compositions for treatment of pulmonary fibrotic disorders |
| 02/24/2011 | US20110044976 Humanized antibodies |
| 02/24/2011 | US20110044971 Method and composition for treating a seratonin receptor-mediated condition |
| 02/24/2011 | US20110044913 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone hemi-fumarate |
| 02/24/2011 | DE102009037551A1 Cyclosporinderivate Cyclosporin derivatives |
| 02/24/2011 | CA2771778A1 Methods and compositions for treatment of pulmonary fibrotic disorders |
| 02/24/2011 | CA2771257A1 Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| 02/24/2011 | CA2770355A1 Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287154A1 Efficient synthesis for the preparation of montelukast |
| 02/23/2011 | EP2286813A2 Use of naphthyridine derivatives as medicaments |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286796A2 Controlled release formulation comprising albuterol |
| 02/23/2011 | EP2285809A1 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use |
| 02/23/2011 | EP2285803A1 5-lipoxygenase-activating protein inhibitor |
| 02/23/2011 | EP2285785A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases |
| 02/23/2011 | EP2285770A1 Process for the synthesis of arformoterol |
| 02/23/2011 | EP2285393A1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndroms |
| 02/23/2011 | EP2285390A1 Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats |
| 02/23/2011 | EP2285372A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/23/2011 | EP2155721B1 Organic compounds |
| 02/23/2011 | EP1697360B1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo 1, 2-a pyridine-6-carboxamide mesylate salt. |
| 02/23/2011 | EP1697347B1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979085A Medicament for treating cough and asthma diseases |
| 02/23/2011 | CN101979080A Phlegm reducing medicament |
| 02/23/2011 | CN101979078A Cough and asthma relieving medicament |
| 02/23/2011 | CN101979066A Atomized liquid for stopping asthma and eliminating phlegm and preparation method thereof |
| 02/23/2011 | CN101979060A Chinese medicament for treating pharyngitis |
| 02/23/2011 | CN101979056A Traditional Chinese medicament for treating asthma |
| 02/23/2011 | CN101979048A Medicinal composition of lonicera confusa and preparation method thereof |
| 02/23/2011 | CN101979047A New medicinal application of pulse-activating injection to chronic obstructive pulmonary disease (COPD) relieving course |
| 02/23/2011 | CN101979046A Medicament for treating tonsillitis |
| 02/23/2011 | CN101979045A Medicament for treating cough and asthma diseases |
| 02/23/2011 | CN101979022A Chinese medicinal mixture for treating chronic rhinitis |
| 02/23/2011 | CN101979015A Chinese medicinal preparation for treating respiratory diseases of chronic tracheitis, emphysema and pulmonary heart disease |
| 02/23/2011 | CN101979002A Process for preparing quick-response cough-relieving capsules |
| 02/23/2011 | CN101978997A Externally-applied cream for treating wind-heat cold by adopting transdermal absorption technology |
| 02/23/2011 | CN101978983A Chinese medicinal composition for treating acute upper respiratory infection and preparation method thereof |
| 02/23/2011 | CN101978981A Medicinal composition for treating oral ulcer and preparation method thereof |
| 02/23/2011 | CN101978964A Compound gentamycin sulfate injection for treating swine plague and preparation method thereof |
| 02/23/2011 | CN101978910A Snake bee nano-selenium element Chinese medicinal anion far infrared multi-functional navel-warming bag shorts |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893242 Oligonucleotide compositions and their use to induce apoptosis |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893112 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893087 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/22/2011 | US7893073 Heterocyclic derivatives |
| 02/22/2011 | CA2486378C Preparation and application of total salvianolic acid |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2463968C Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 02/22/2011 | CA2398163C Therapeutic morpholino-substituted compounds |
| 02/22/2011 | CA2392685C Antisense antibacterial method and composition |
| 02/17/2011 | WO2011019681A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | WO2011018588A2 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018587A2 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018510A1 New macrolides and their use |
| 02/17/2011 | WO2010123959A3 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 02/17/2011 | WO2010042701A3 Corticosteroid compositions for use in treating diseases of the upper and lower airway passages |
| 02/17/2011 | US20110040240 Methods for treating rhinitis and conjunctivitis |
| 02/17/2011 | US20110039920 Inhibitors of ikk-beta serine-theronine protein kinase |
| 02/17/2011 | US20110039866 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | US20110039852 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 02/17/2011 | US20110039851 Ccr10 antagonists |
| 02/17/2011 | US20110039848 Five-membered ring compound |
| 02/17/2011 | US20110039829 Pyrazole-carboxamide derivatives as p2y12 antagonists |
| 02/17/2011 | US20110039812 N-alkylcarbonyl-d-amino hydroxyalkyl ester compounds and their use |
| 02/17/2011 | US20110039801 Nk1 receptor antagonist composition |
| 02/17/2011 | US20110039795 2'-o,3'-n-bridged macrolides |
| 02/17/2011 | US20110039759 Use of Secretin-Receptor Ligands in Treatment of Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD) |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038885 Chemokine analogs |
| 02/17/2011 | US20110038882 Methods for Treating Allergic Disease |
| 02/17/2011 | US20110038869 Monoclonal antibodies against cd32b |
| 02/17/2011 | US20110038835 Anilides and analogs as rho kinase inhibitors |
| 02/17/2011 | US20110038806 Medicaments for inhalation comprising an anticholinergic and a steroid |
| 02/17/2011 | CA2808582A1 Imidamide sphingosine kinase inhibitors |
| 02/17/2011 | CA2771083A1 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | CA2771056A1 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771055A1 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2770896A1 Cathepsin c inhibitors |
| 02/17/2011 | CA2769551A1 New macrolides and their use |
| 02/16/2011 | EP2284192A2 Camelidae antibodies for sublingual administration |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2283867A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
| 02/16/2011 | EP2283866A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |